Pharma Pulse 3/11/25: Integrated Multi-Omic Data, What’s Changed and What Hasn’t Following the COVID-19 Pandemic & more

Integrated Multi-Omic Data: Powering Precision Medicine

Genomics has long been a primary focus in precision medicine, but other areas of research are increasingly being used to help attain a more complete picture of how an individual’s complex biology impacts their health profile.

Has It Really Been 5 Years? What’s Changed and What Hasn’t Following the COVID-19 Pandemic

COVID-19 changed the personal and professional lives of all pharmacy workforce members. But what now?

Senators Say Kennedy Must Disclose Details on Drugmaker Meetings

Three senators are calling on Health and Human Services Secretary Robert F. Kennedy Jr. to disclose what he and President Donald Trump discussed with drugmakers during closed-door conversations.

GoodRx Report Reveals Striking Gender Divide in Prescription Medication Spending

GoodRx has released a new report, The Prescription Drug Gender Divide, detailing how women shoulder a significantly greater out-of-pocket cost burden than men. The data shows that in 2024, women spent $8.8 billion – or 30% – more than men on out-of-pocket prescription costs. Combined with the common responsibilities of managing a career, family planning, and caregiving, women are left frustrated with the financial pressure required to maintain their health.

Pharmaceutical Executive on LinkedIn

Good News! The deadline for submissions has been extended!

Do you know someone who is driving innovation across R&D, market access, or commercialization? Or maybe you deserve the recognition yourself.

Don't miss this final opportunity to honor pharma's next generation of leaders.

Submit your entry now: https://ow.ly/bTpy50Vf5QV

Have news you want us to share in Pharma Pulse? Reach out to Editor Miranda Schmalfuhs